GP IIb/IIIa inhibitors in coronary artery disease management: What the latest trials tell us

D. P. Chew, D. J. Moliterno

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'GP IIb/IIIa inhibitors in coronary artery disease management: What the latest trials tell us'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science